Vimarsana
Biggest News Aggregation in the World

Page 35 - Query Get News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Query Get. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Query Get Today - Breaking & Trending Today

Fast-track rehabilitation after THR yielded shorter stays, better functional outcomes - Vimarsana News

Fast-track rehabilitation after THR yielded shorter stays, better functional outcomes

Patients who received fast-track rehabilitation after total hip replacement experienced shorter hospital stays and better functional outcomes compared with patients who had conventional rehabilitation, according to results.Researchers randomly assigned 60 patients undergoing THR for hip arthritis to participate in conventional rehabilitation after a normal hospital stay or a fast-track

Source: healio.com
Those with psychiatric illness less likely to be tested, vaccinated than general population - Vimarsana News

Those with psychiatric illness less likely to be tested, vaccinated than general population

Those hospitalized for psychiatric illness were less likely to be tested for COVID-19 and had lower confirmed infection rates but higher risk for COVID-19-related mortality than the general population, per a study from Molecular Psychiatry. “Many authors have recommended prioritization of COVID-19 vaccination for people with severe mental illness, and some but not all studies reported lower

Source: healio.com
Ibrutinib shows promise for children with chronic graft-versus-host disease - Vimarsana News

Ibrutinib shows promise for children with chronic graft-versus-host disease

SALT LAKE CITY — Ibrutinib appeared safe and effective for children with previously untreated or relapsed/refractory chronic graft-versus-host disease, according to study results. Paul A. Carpenter, MD, professor at Fred Hutchinson Cancer Research Center, presented the results at Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR.

Source: healio.com
FDA approves mavacamten, first treatment for obstructive hypertrophic cardiomyopathy - Vimarsana News

FDA approves mavacamten, first treatment for obstructive hypertrophic cardiomyopathy

The FDA approved mavacamten for the treatment of symptomatic, obstructive hypertrophic cardiomyopathy, the first cardiac myosin inhibitor to be permitted for use in the United States, Bristol Myers Squibb announced.Mavacamten (Camzyos, Bristol Myers Squibb) is the first and only FDA-approved allosteric and reversible inhibitor selective for cardiac myosin that targets the underlying

Source: healio.com
Factors predict survival after immunotherapy combination for HNSCC - Vimarsana News

Factors predict survival after immunotherapy combination for HNSCC

DALLAS — Multiple factors predicted improved survival among patients with head and neck or salivary gland cancers treated with pembrolizumab plus vorinostat, according to prospective study results.Patients with lower pretreatment neutrophils and neutrophil-to-lymphocyte ratios — as well as those with more pretreatment lymphocytes and T helper cells — achieved longer OS and PFS,

Source: healio.com